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Abstract
Background: Metastatic tumours sometimes present with neuropsychiatric symptoms, however psychiatric symptoms as rarely the first clinical manifestation. 
Cutaneous melanoma is the third most common cause of brain metastasis, with known risk factors increasing the chance of such central nervous system 
metastization. Objectives: We present a clinical report of delirium as the first clinical manifestation of melanoma brain metastases, illustrating the relevance 
of an adequate and early differential diagnosis. Methods: In addition to describing the clinical case, searches were undertaken in PubMed and other databases 
using keywords such as “brain metastasis”, “melanoma”, “agitation”, “psychiatric” and “delirium”. Results: We here report the case of a 52-year-old female patient 
evaluated by Liaison Psychiatry after sudden onset of delirium while admitted at the Gastroenterology Department to study a hypothesis of pancreatitis. A 
head CT scan identified brain metastases, and after further examination, including brain biopsy, melanoma brain metastization was confirmed. Discussion: 
Some of the diagnostic challenges of psychiatric symptoms associated with secondary brain tumours are discussed, underlining the importance of an adequate 
differential diagnosis when working in Psychiatry Liaison.
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Dear Editor,
We report a clinical case of sudden onset of delirium, with 
psychomotor agitation and behavioural changes, in addition to 
reported depressive symptoms of subacute onset, as the initial 
manifestation of melanoma brain metastasis in the right posterior 
frontal lobe.
Our Psychiatry Liaison Unit was requested to attend a female 
patient, 52-year-old, that was admitted from the Emergency 
Department with nausea, vomiting and headache, initiated 2 
days before. She had no psychiatry history other than depressive 
symptoms, about 9 months long, apparently reactive to work conflicts, 
medicated with paroxetine 20 mg id. Medical history included the 
excision of an ulcerated malignant melanoma in the right thigh 4 
years before, in apparent remission, and hysterectomy for uterine 
fibroid. Her neurological exam was unremarkable. Blood analysis 
showed hepatic cholestasis and abdominal ultrasound showed 
a pancreatic mass; she was hospitalized at the Gastroenterology 
Department with a hypothetic pancreatitis.
After three days she initiated during the night psychomotor 
agitation and disinhibited behaviour, motivating Psychiatry Liaison 
consultation. When interviewed next morning, she was still restless 
and fidgeting in the sheets, with spatiotemporal disorientation, 
speaking quickly with a somehow incoherent speech, keeping her 
eyes closed and stating: “Doctor I have flatulence, but you know me 
and this is funny...”
An urgent head computerized tomography (CT) scan was 
performed evidencing an expansive lesion within the right posterior 
frontal lobe, heterogeneous and hyperdense, conditioning mass effect 
on adjacent structures. She started oral haloperidol 5 mg id and 
performed a head magnetic resonance imaging (MRI) (Figure 1).
Later, a chest/abdomen/pelvis CT scan and a whole-body 
Positron Emission Tomography (PET) scan identified multi-organic 
metastatic disease affecting the lungs, pancreas and peritoneum. The 
patient was also medicated with oral dexamethasone and transferred 
to the Neurosurgery Department. She underwent surgical removal 
of part of the brain lesion, with a biopsy consistent with melanoma 
brain metastases.
Figure 1. Brain MRI. (A) Axial T1-weighted image showing a cortico-
-subcortical tumoral lesion at temporal lobe with predominant moderate 
hyperintensity and an irregular halo of higher signal. The spontaneous high 
signal on T1 is probably due to both a hemorragic component and the mela-
nocytic content. (B) Coronal T2-weighted image showing the lesion described 
in (A) and additional two smaller cortico-subcortical masses located at right 
posterior frontal lobe and at left inferior temporal gyrus. All the lesions 
had low signal on T2, particularly the inferior solid component of the major 
tumoral mass, which is also compatible with a melanocytic content. Another 
milimetric lesion was found at left precuneus (not shown). The hypointensity 
on T2-weighted image (B) may also be associated at lung or gastrointestinal 
adenocarcinoma metastasis, however with the (A) axial T1-weighted image 
the hyperintense signal is typical of melanoma melanocytic.
Cutaneous melanoma is the third most common cause of brain 
metastasis, reflecting its distinctive neurotropism1. Central nervous 
system (CNS) metastasis occur in 10 to 40% of melanoma patients 
in clinical studies and up to 90% in autopsy studies2. Nonetheless, to 
our knowledge, this is the first report in the literature of delirium as 
a presenting syndrome of melanoma brain metastases.
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Factors that have been shown to increase the risk for development 
of CNS metastasis in melanoma patients included male sex, thickness 
or ulceration of the skin lesion, primary site in the head and neck, 
mucosal or acral lentiginous tumors and nodular primary lesions3. 
Metastatic tumors often present with more neuropsychiatric 
symptoms4. Most brain tumors present with specific neurologic 
signs due to mass effect, and 78% of patients with brain tumors 
had psychiatric symptoms, but only 18% presented only with these 
symptoms as the first clinical manifestation of a brain tumor5. 
Depression was found in 44% of all brain tumor patients, primary 
and metastatic6.
We report a rare case associating delirium with the early 
presentation of brain metastization of melanoma. Clinical suspicion 
is critical when working in Psychiatry Liaison, and an adequate 
differential diagnosis is key to the early treatment of potentially fatal 
CNS conditions.
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